EVH Evolent Health, Inc.

3.430USD-12.72%Mkt Cap: 387.95M USDP/E: —

Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform…

Insiders, last 90 daysNet sellers
Institutional holders20 on file

Key Statistics

Company
Market Cap387.95M USD
Enterprise Value1.27B USD
Revenue (TTM)2.34B USD
Gross Profit399.88M USD
Net Income (TTM)-534.51M USD
Revenue/Share20.87 USD
Last Price3.430 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees4.2K
CountryUS
SectorHealthcare
IndustryHealth Information Services
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)8.11
PEG1.93
EV/EBITDA22.66
EV/Revenue0.54
P/S0.17
P/B1.04
EPS (TTM)-4.46 USD
EPS (Forward)0.42 USD
52W Range
2.09532% of range6.255
52W High6.255 USD
52W Low2.095 USD
Profitability
Gross Margin21.31%
Oper. Margin-1.30%
EBITDA Margin2.39%
Profit Margin-28.49%
ROE-128.74%
ROA-28.14%
ROIC-1.58%
ROCE-1.31%
Growth
Revenue Growth51.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF38.84M USD
CapEx (TTM)34.09M USD
FCF Margin6.10%
FCF Yield36.82%
Net Debt824.79M USD
Net Debt/EBITDA14.72
Net Debt/FCF5.77
Balance Sheet
Debt/Equity2.38
Current Ratio1.26
Quick Ratio1.21
Book Value/Sh3.30 USD
Cash/Share1.31 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.7 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)6.000 USD
Upside (mean)+74.9%
Target Range3.000 USD – 8.000 USD
3.000+74.9% to mean8.000
# Analysts12
Ownership
Shares Out.113.11M
Float100.09M
Insiders3.10%
Institutions91.47%
Short Interest
Short Ratio5.8d
Short % Float9.48%
Short % Out.9.38%
Shares Short10.61M
Short (prev mo.)12.91M
Technical
SMA 504.228 (-18.9%)
SMA 2003.928 (-12.7%)
Beta1.02
S&P 52W Chg12.08%
Avg Vol (30d)1.82M
Avg Vol (10d)1.92M
Technical Indicators
RSI (14)32.2
MACD-0.0327
MACD Signal0.0917
MACD Hist.-0.1245
BB Upper5.249 USD
BB Middle4.514 USD
BB Lower3.779 USD
BB Width32.56%
ATR (14)0.3683 USD
Vol Ratio (20d)1.85x

About Evolent Health (NYSE: EVH)

›

Evolent Health (NYSE: EVH) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Health Information Services industry, part of the Healthcare sector, and reports about 4,200 employees.

The shares were at 3.430 USD on 19 November 2026, down 17.9% over 52 weeks. Its 52-week range is 2.095 USD to 6.255 USD: the price is 45.2% below the high and 63.7% above the low.

Its market capitalisation is 387.95M USD.

Evolent Health reports return on equity of -128.7%, an operating margin of -1.3% and revenue up 51.3% year over year.

Its debt exceeds its cash by 824.79M USD, a debt-to-equity ratio of 2.38. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 12 analysts cover the stock, with an average rating of Buy; their mean price target of 6.000 USD is 74.9% above the current price. The next earnings report is expected on 23 February 2027.